NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
April 23, 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
April 10, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 27, 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
March 25, 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
March 07, 2024 08:22 ET
|
Neuronetics
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
March 05, 2024 07:30 ET
|
Neuronetics
MALVERN, Pa., March 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
February 20, 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
February 12, 2024 08:32 ET
|
Neuronetics
MALVERN, Pa., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
February 06, 2024 08:28 ET
|
Neuronetics
MALVERN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...